Skip to content

Clinical trials

Phase 1/2 Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1/2 Country / region: Brazil Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20091
20121
20211
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Unknown status2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
BeOne Medicines1
Butantan Institute1
D'Or Institute for Research and Education1
Daiichi Sankyo1
GlaxoSmithKline1
Instituto de Investigação em Imunologia1
Merck Sharp & Dohme LLC1
Nereus Pharmaceuticals, Inc.1
Threshold Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms10
Lung Neoplasms2
Neoplasm Metastasis2
Breast Neoplasms1
COVID-191
Carcinoma, Non-Small-Cell Lung1
Cardiovascular Diseases1
Diabetes Mellitus1
Kidney Diseases1
Lymphoma, B-Cell1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.